Prof. Shaoqin Gong, Dr. Zachary Morris, Ying Zhang and Raghava Sriramaneni. This interdisciplinary team is bridging medicine and nanotechnology to confront cancer. The combination of their novel nanoparticle, radiation therapy and a checkpoint inhibitor could render more tumors more treatable by immunotherapy.
- Shaoqin Gong, Professor of Biomedical Engineering at UW-Madison
- Zachary Morris, Assistant Professor of Human Oncology at UW-Madison
- Ying Zhang, Postdoctoral Associate in Biomedical Engineering at UW-Madison
- Raghava Sriramaneni, Researcher in Human Oncology at UW-Madison